Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.65 is 35% above its 5-year average of -1.00, around the middle of its 5-year range (-1.85–-0.13).
2.36% below its 12-month average of -0.64.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.18.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 27 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:25:27.551Z. Historical observations retain their original dates. Historical series through 2024-05-07.
EARNINGS PER SHARE (EPS)
-0.65
EARNINGS PER SHARE (EPS) AVG TTM
-0.64
EARNINGS PER SHARE (EPS) AVG 3Y
-0.63
EARNINGS PER SHARE (EPS) AVG 5Y
-1.00
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-2.36%
CURRENT VS 3Y AVG
-3.17%
CURRENT VS 5Y AVG
+35.32%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Aquestive Therapeutics, Inc.
Market Cap
$573.38M
Earnings Per Share (EPS)
-0.65
TTM Avg
-0.64
3Y Avg
-0.63
5Y Avg
-1.00
Market Cap
$569.56M
Earnings Per Share (EPS)
2.13
TTM Avg
0.97
3Y Avg
0.08
5Y Avg
-0.20
Market Cap
$579.88M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.57
3Y Avg
-1.57
5Y Avg
-1.57
Market Cap
$561.67M
Earnings Per Share (EPS)
-0.45
TTM Avg
0.12
3Y Avg
-0.31
5Y Avg
-0.31
Market Cap
$587.93M
Earnings Per Share (EPS)
-1.68
TTM Avg
-1.67
3Y Avg
-1.05
5Y Avg
-1.14
Market Cap
$551.09M
Earnings Per Share (EPS)
-0.88
TTM Avg
-0.82
3Y Avg
-0.78
5Y Avg
-1.65
Market Cap
$596.36M
Earnings Per Share (EPS)
-0.58
TTM Avg
-1.12
3Y Avg
-1.21
5Y Avg
-1.27
Market Cap
$547.86M
Earnings Per Share (EPS)
0.01
TTM Avg
0.08
3Y Avg
-2.02
5Y Avg
-4.00
Market Cap
$600.84M
Earnings Per Share (EPS)
0.77
TTM Avg
0.08
3Y Avg
-1.29
5Y Avg
-0.21
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | $573.38M | -0.65 | -0.64 | -0.63 | -1.00 |
| CorMedix Inc. (CRMD)vs › | $569.56M | 2.13 | 0.97 | 0.08 | -0.20 |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $579.88M | N/A | -1.57 | -1.57 | -1.57 |
| CytomX Therapeutics, Inc. (CTMX)vs › | $561.67M | -0.45 | 0.12 | -0.31 | -0.31 |
| OrthoPediatrics Corp. (KIDS)vs › | $587.93M | -1.68 | -1.67 | -1.05 | -1.14 |
| Immix Biopharma, Inc. (IMMX)vs › | $551.09M | -0.88 | -0.82 | -0.78 | -1.65 |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $596.36M | -0.58 | -1.12 | -1.21 | -1.27 |
| Delcath Systems, Inc. (DCTH)vs › | $547.86M | 0.01 | 0.08 | -2.02 | -4.00 |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $600.84M | 0.77 | 0.08 | -1.29 | -0.21 |
| Altimmune, Inc. (ALT)vs › | $519.25M | -0.78 | -1.17 | -1.45 | -1.68 |
Trailing EPS (TTM)
$-0.65
Forward EPS (Est.)
$-0.49
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.76 |
| 2024-12-31 | -0.51 |
| 2023-12-31 | -0.13 |
| 2022-12-31 | -1.12 |
| 2021-12-31 | -1.85 |
| 2020-12-31 | -1.66 |
| 2019-12-31 | -2.87 |
| 2018-12-31 | -2.96 |
| 2017-12-31 | -0.45 |
| 2016-12-31 | -0.39 |
